Filing Details
- Accession Number:
- 0001203311-20-000132
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-23 20:11:12
- Reporting Period:
- 2020-11-19
- Accepted Time:
- 2020-11-23 20:11:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202335 | W David Gryska | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-19 | 7,129 | $19.02 | 51,977 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-19 | 7,129 | $174.20 | 44,848 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-19 | 7,871 | $19.02 | 52,719 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-19 | 7,871 | $173.25 | 44,848 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-19 | 7,129 | $0.00 | 7,129 | $19.02 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-19 | 7,871 | $0.00 | 7,871 | $19.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,871 | 2021-05-20 | No | 4 | M | Direct | |
| 0 | 2021-05-20 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $173.75 to $174.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $172.75 to $173.74 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/20/12.
Billionaire Hedge Funds
